SahPK, TeagueWG, DemuthKA, et al.Poor asthma control in obese children may be overestimated because of enhanced perception of dyspnea. J Allergy Clin Immunol Pract, 2013; 1:39–45.
2.
TeagueWG. Lawrence MG, Shirley DT, et al. Lung lavage granulocyte patterns and clinical phenotypes in children with severe, therapy-resistant asthma. J Allergy Clin Immunol Pract, 2019; 7:1803–1812.
3.
PetersSP, JonesCA, HaselkornT, et al.Real-world evaluation of asthma control and treatment (REACT): findings from a national Web-based survey. J Allergy Clin Immunol, 2007; 119:1454–1461.
4.
TeagueWG, PhillipsBR, FahyJV, et al.Baseline features of the Severe Asthma Research Program (SARPIII) Cohort: differences with age. J Allergy Clin Immunol Pract, 2018; 6:545–554.
5.
FitzpatrickAM, TeagueWG, MeyersDA, et al.Heterogeneity of severe asthma in childhood: confirmation by cluster analysis of children in the NIH/NHLBI Severe Asthma Research Program. J Allergy Clin Immunol,, 2011; 127:382–389.
6.
WisniewskiJA, MuehlingLM, EcclesJD, et al.TH1 signatures are present in the lower airways of children with severe asthma, regardless of allergic status. J Allergy Clin Immunol, 2018; 141:2048–2060.
7.
AltesTA, MuglerJP, RuppertK, et al.Clinical correlates of lung ventilation defects in children with asthma. J Allergy Clin Immunol, 2016; 137:789–796.
8.
ChungKF, WenzelSE, BrozekJL, et al.International ERS/ATS consensus definition, mechanisms, evaluation and treatment of severe asthma. Eur Respir J, 2014; 43: 343–373.
9.
HarrisDA, MainardiA, IyamuO, et al.Improving the asthma disparity gap with legal advocacy? A qualitative study of patient-identified challenges to improve social and environmental factors that contribute to poorly controlled asthma. J Asthma, 2018; 55: 924–932.
10.
HarrisD, GrahamL, TeagueWG. Not one more life: a health and faith partnership engaging at-risk African Americans with Asthma in Atlanta. Ann Am Thor Soc, 2019; 16: 421–425.
